Achillion: ACH-3102 Interim Results (Achillion) - Jan 22, 2013 - Anticipated initial sustained virological response data from P2 (ACH-3102 + RBV combo) trial for HCV in Q2 2013; Anticipated expansion of enrollment to include non-CC GT 1b treatment-naïve patients in P2 (ACH-3102 + RBV combo) trial in Q1 2013
Anticipated enrollment status • Anticipated P2 data • Hepatitis C Virus
|